CF PharmTech (HKG:2652) said Chinese regulators had accepted its marketing authorization application for tiotropium bromide inhalation powder for review, according to a Tuesday filing with the Hong Kong bourse.
The product is designed to treat bronchospasm associated with chronic obstructive pulmonary disease and help keep reduce exacerbations associated with the condition.
Abacus Group (ASX:ABG) named Mark Haberlin, a non-executive director and lead independent director, as independent chair of the board, succeeding Myra Salkinder, according to a Tuesday filing with the Australian bourse.Salkinder will retire from the board on June 30, the filing said.Shares rose 1% in midday trade on Tuesday.
MeGroup (SGX:SJY) booked a loss attributable to equity holders of 2.1 million Malaysian ringgit in the fiscal second half ended March 31, against an attributable profit of 1.0 million ringgit a year earlier, according to a Tuesday filing with the Singapore Exchange.Loss per share came in at 0.0177 ringgit compared with earnings per share of 0.0085 ringgit in the year-ago period.Revenue declined 15% year over year to 168.5 million ringgit from 199.2 million ringgit.
China Film (SHA:600977) Chairman Fu Ruoqing stepped down upon reaching retirement age, according to a Tuesday filing with the Shanghai bourse.Fu took office in 2022. The film company has yet to name his successor.